A 2-treatment period, randomized, placebo-controlled, multicenter parallel-group study to assess the safety of QAW039 when added to existing asthma therapy in GINA steps 3, 4 and 5 patients with uncontrolled asthma
|
Terminated
|
QAW039/Fevipiprant
|
3
|
CQAW039A2315
|
KFMC
|
A 2-treatment period, randomized, placebo-controlled, multicenter parallel-group study to assess the safety of QAW039 when added to existing asthma therapy in GINA steps 3, 4 and 5 patients with uncontrolled asthma
|
Terminated
|
QAW039/Fevipiprant
|
3
|
CQAW039A2315
|
KFMC
|
A 24 month, randomized, controlled, study to evaluate the efficacy and safety of concentration-controlled everolimus plus reduced tacrolimus compared to standard tacrolimus in recipients of living donor liver transplants
|
Completed
|
Everolimus + reduced tacrolimus VS.Tacrolimus
|
3
|
CRAD001H2307
|
KFSH & RC-R
|
“MERS-CoV Infection Treated with a Combination of Lopinavir/Ritonavir and Interferon Beta 1B: A Placebo-Controlled, Double-Blind Randomized Trial (MIRACLE Trial)”
|
Completed
|
Kaletra
|
3
|
RC15/142/R
|
NGHA-R
|
"RAINBOW extension study: an extension study to evaluate the long term efficacy and safety of RAnibizumab compared with laser therapy for the treatment of Infants BOrn prematurely With retinopathy of prematurity"
|
Completed
|
Ranibizumab
|
3
|
CRFB002H2301E1
|
KFSH & RC-R
|
Phase 3, Open/Label Study to evaluate the safety and efficacy of TMC 435 plus Pegylated Interferon alfa-2a and Ripavirin administrated for 12 weeks in treatment-naïve Subjects with Chronic genotype 1 or genotype 4 HCV infection
|
Completed
|
TMC435 (simeprevir)
|
3b
|
TMC435HPC3014
|
KFSH & RC-R
|
An Open-Label, Multinational, Multicenter, Phase IIIB Study With Subcutaneus Administration Of Trastuzumab In Patient With Her2-Positive Early Breast Cancer To Evaluate Patient Satisfaction
|
Terminated
|
Trastuzumab SC
|
3b
|
ML28851
|
KKUH (Closed)
|
An Open-label, Multicentre, Randomised, 2-arm Study to Investigate the Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose Versus Oral Iron for the Treatment of Iron Deficiency Anaemia in Pregnant Women
|
|
|
3
|
|
|
A RANDOMIZED, PARTIALLY-BLIND, PLACEBO-CONTROLLED, PILOT, DOSE-RANGING STUDY TO ASSESS THE EFFECT OF GWP42003 ON LIVER FAT LEVELS IN SUBJECT WITH FATTY LIVER DISEASE
|
Rejected
|
Cannabidiol
|
2a
|
GWZMD1188
|
KKUH
|
A Phase III, Multicenter, Randomized, Open-Lable Clinical Trial Comparing the Efficacy and Safety of MK-0431 A (the Fixed-Dose Combination of Sitagliptin and Metformin) to That of Liraglutide in Patients With Type 2 Diabetes Mellitus
|
Terminated
|
MK-0431A (Sitagliptin / Metformin) vs Liraglutide
|
3
|
MK-0431A-180-00
|
KKUH
|